FDA Okays Pitolisant (Wakix) for Narcolepsy

The FDA has approved pitolisant, a first-in-class, nonscheduled treatment option with a novel mechanism of action for adults with narcolepsy.
FDA Approvals

Source link

Related posts

Assessing MS Risk Factors With Machine Learning Technologies


Opinion and Special Articles: Self-management in epilepsy: Web-based seizure tracking applications


Getting to the Roots of Pessimism


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy